Resources

Products
- For Providers
- For Life Sciences
Platform
Resources
Company
Press
- Media InsightRX in the news — digital, print, podcasts, and other outlets
- Press Releases Announcements for events, partnerships, and company updates

FEATURED POST

InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution

Home
Resources
Blog

Search Blog section Author Tags

Product Innovation

Sep 5, 2025

New Continuous Learning PK Model Outperforms Published PopPK Models for Gentamicin

Thought Leadership

Apr 24, 2025

Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing

Thought Leadership

Sep 18, 2024

Overcoming barriers to beta-lactam TDM through Bayesian model-informed precision dosing

Thought Leadership

Jun 28, 2024

AUC Monitoring for Vancomycin: Comparing Estimation Methods

Thought Leadership

Jun 13, 2024

Recognizing the value of therapeutic drug monitoring for beta-lactam antibiotics

Product Innovation

Mar 25, 2022

Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas

Maximize therapeutic success with precision medicine.

What We Do

For Providers

Bayesian Dosing (MIPD)
Real-Time Dosing Analytics
Available Drug Modules

For Life Sciences

Precision Dosing in Clinical Trials
PKPD Analytics in Clinical Trials
Companion Applications

How We Do It

Continuous Learning
Integrations
Security & Regulatory
Success & Support
Data Science

Information

Product Innnovation
Scientific Publications
Thought Leadership
White Papers
How to Cite InsightRX

Press

Media
Press Releases

About

Contact Us
Customers
Leadership
Advisory Board
Mission & Vision
Careers

548 Market Street
#88083
San Francisco, CA 94104

View our privacy policy

InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance

FEATURED POST

New Continuous Learning PK Model Outperforms Published PopPK Models for Gentamicin

Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing

Overcoming barriers to beta-lactam TDM through Bayesian model-informed precision dosing

AUC Monitoring for Vancomycin: Comparing Estimation Methods

Recognizing the value of therapeutic drug monitoring for beta-lactam antibiotics

Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas

What We Do

For Providers

For Life Sciences

How We Do It

Information

Resources

Press

About

548 Market Street#88083San Francisco, CA 94104

548 Market Street#88083San Francisco, CA 94104

548 Market Street
#88083
San Francisco, CA 94104

548 Market Street
#88083
San Francisco, CA 94104